Hyper Light Technologies Partners with Forma Life Sciences to Provide Marketing and Product Design Support to Accelerate the Company’s Commercial Solutions for Healthcare Acquired Infections
Cary, NC, September 18, 2018 –Hyper Light Technologies and Forma Life Sciences are pleased to announce they have entered into a strategic partnership, combining Hyper Light’s UV-based research with Forma’s strategic marketing and product design expertise to deliver a next-gen surface disinfection technology to the healthcare market. The partnership brings together deep skills in science, product ideation, technology development and deployment.
“The Hyper Light-Forma partnership is a strategic combination. Forma’s understanding of complex product design, their deep engineering expertise, and collaborative approach is uniquely complimentary to how the Hyper Light team works. We believe this partnership will expand our current capabilities and advance us closer to our prototype development and commercial goals” said C.G. Gillooly, Hyper Light, CEO.
“This partnership will allow us to fuse a decade of technology development into an end-user design, and build a patient-friendly solution the market so desperately needs for this fight against HAIs” said David Chapin, Forma, CEO.
Additionally, David Chapin will act as the VP of Product Development for the Company as Hyper Light works towards their commercial goals.
Hyper Light is passionate about the fight against HAIs, as all members of the company have had the HAI battle personally touch their lives. Hyper Light projects a late 2020 launch of their first surface disinfection device.
About Hyper Light Technologies
Hyper Light is a privately held, technology platform company located near Research Triangle Park, North Carolina. Our mission is to transform today’s current disinfection approaches by harnessing UV light to combat pathogens. For more information, visit www.hplight.com.